Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Uronext in Women With Acute Cystitis
NCT05945667Completed
- Sponsor
- PharmaLinea
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by PharmaLinea. Primary endpoint: Number of cystitis relapses at 3 months. Started Jun 2021; status: completed.
Beyond the preview
Go deeper on NCT05945667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05945667.